The Gujarat Kidney Super Speciality IPO marks an important development in India’s regional healthcare space, particularly within tertiary healthcare services. Hospital Gujarat Kidney is recognized as a leading facility in the region, offering specialized kidney and multispecialty treatments. Gujarat superspeciality hospital plays a significant role in providing advanced healthcare services and state-of-the-art infrastructure to patients across the state. Operating as a super speciality hospital network in central Gujarat, including the City Sarve locality, the company focuses on renal sciences, surgical treatments, and multispeciality healthcare services. With increasing demand for kidney and super speciality care in Tier II and Tier III cities, the Gujarat Kidney IPO has attracted attention from retail investors tracking healthcare IPO investments.
Gujarat Kidney and Super Speciality: Company Overview
Gujarat Kidney & Super Speciality Limited operates as a regional healthcare provider offering tertiary care services across kidney and super speciality disciplines. The hospital ecosystem includes Gujarat Kidney, Gujarat Surgical Hospital, and Gujarat Multispeciality Hospital facilities, with one of the hospitals located at Gokak Mill Compound in Vadodara and another facility situated on a Super Speciality Limited Plot, serving patients from Vadodara location and nearby regions in India.
The company also expanded its footprint through inorganic growth and acquired Ashwini Medical Centre, strengthening its presence in super speciality hospital services. The purchase consideration for the acquisition of Ashwini Medical Centre was a key part of the company's financial strategy for growth. Operations span internal medicine, renal sciences, trauma treatment, non-interventional cardiology, and minimally invasive procedures. The group also runs in-house pharmacies, including Ashwini Medical Store, and supports secondary care services alongside superspeciality hospital offerings.
Kidney and Super Speciality Healthcare Services
As a kidney and super speciality healthcare platform, Gujarat Kidney Super Speciality focuses on advanced tertiary healthcare services such as dialysis-linked renal care, surgical treatments, joint replacement surgery, and trauma care. The hospital ecosystem includes facilities like Parekhs Hospital, Surya Hospital, and KMC Speciality Hospitals, creating a diversified multispeciality healthcare services model.
The use of robotics equipment, advanced surgical procedures, and specialised infrastructure helps deliver improved patient outcomes. The company positions itself as a super speciality hospital chain catering to both tertiary care and secondary care services across central Gujarat.
Gujarat Kidney Super Speciality IPO Details
The Gujarat Kidney Super Speciality IPO is a Fresh Capital issue, aimed at supporting hospital expansion, capital expenditure requirements, and strengthening the balance sheet. Part of the IPO proceeds will be used for repayment or prepayment of certain outstanding secured borrowings. The company also plans to address outstanding secured borrowings availed as part of its debt management strategy. Additionally, a portion of the funds may be allocated for unidentified acquisitions to support inorganic growth.
IPO Details Table
| Particulars | Details |
|---|---|
| IPO Name | Gujarat Kidney Super Speciality IPO |
| IPO Date | December 22, 2025 to December 24, 2025 |
| Listing At | BSE, NSE |
| Issue Type | Bookbuilding IPO |
| Face Value | ₹2 per share |
| Gujarat Kidney IPO Price Band | ₹108 to ₹114 |
| Sale Type | Fresh Capital |
| Total Issue Size | 2,20,00,000 equity shares |
| Shareholding Pre Issue | 5,68,43,250 shares |
| Shareholding Post Issue | 7,88,43,250 shares |
| Registrar | MUFG Intime India Pvt Ltd |
Gujarat Kidney IPO Timeline and IPO Listing Date
The Gujarat Kidney IPO listing date is scheduled post allotment and refund timelines as follows:
IPO Timeline
| Event | Date |
|---|---|
| IPO Opens | Mon, Dec 22, 2025 |
| IPO Closes | Wed, Dec 24, 2025 |
| Tentative Allotment | Fri, Dec 26, 2025 |
| Initiation of Refunds | Mon, Dec 29, 2025 |
| Credit of Shares to Demat | Mon, Dec 29, 2025 |
| Tentative Listing Date | Tue, Dec 30, 2025 |
| UPI Cut-off Time | 5 PM on Dec 24, 2025 |
The IPO price band and lot size are yet to be announced as per the draft red herring prospectus. The super speciality IPO GMP (grey market premium) will be closely watched, as it reflects market sentiment and can influence the IPO's valuation before listing.
Gujarat Kidney IPO Price Band
The Gujarat Kidney Super Speciality IPO price band has now been announced at ₹108 to ₹114 per equity share. Investors can use this finalized price range to evaluate the IPO and plan their subscription strategy accordingly before applying.
Financial Performance of Gujarat Kidney Super Speciality Limited
The financial performance of Gujarat Kidney & Super Speciality Limited shows strong operating and financial performance, especially after recent expansion and acquisitions.
Financial Information Table (₹ Crore)
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| Net Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves & Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | — |
The company reported a 637% increase in revenue and 454% growth in profit after tax, indicating sharp operational scale-up post acquisitions and hospital expansion.
Market Trends and Opportunities in the Healthcare Sector
India’s healthcare sector is experiencing robust expansion, fueled by rising demand for quality medical care, rapid technological advancements, and supportive government policies aimed at strengthening healthcare infrastructure. Gujarat Kidney and Super Speciality Limited stands out as a key player in this evolving landscape, leveraging its expertise in tertiary healthcare services and multispeciality healthcare services to meet the needs of a growing patient base.
The hospital segment remains the cornerstone of the Indian healthcare market, accounting for nearly 80% of total healthcare expenditure. With the market projected to reach $372 billion by 2025 and a CAGR of 16-17%, super speciality hospitals like Gujarat Kidney and Super Speciality Hospital, Gujarat Multispeciality Hospital, and Ashwini Medical Centre are well-positioned to capture a significant share of this growth. The company’s focus on advanced super speciality surgical procedures, internal medicine, and non-interventional cardiology aligns perfectly with the increasing demand for specialized and tertiary care services.
Strategic expansion initiatives, such as the acquisition of Parekhs Hospital Private Limited and the development of a new hospital in the Vadodara location, further strengthen Gujarat Kidney’s regional presence. The integration of robotics equipment at the superspeciality hospital enhances the company’s ability to deliver cutting-edge surgical treatments, attracting patients seeking high-quality care from across Gujarat and neighboring states.
From a financial perspective, Gujarat Kidney and Super Speciality Limited has demonstrated impressive performance, with a 22% CAGR in revenue over the past three years and an EBITDA margin reaching 25% in FY25. These metrics underscore the company’s operational efficiency and profitability, making the upcoming super speciality limited IPO particularly attractive. The anticipated IPO price band is expected to reflect the company’s strong fundamentals and growth prospects.
Investors interested in the Gujarat Kidney IPO can apply through multiple channels, including ASBA, UPI, and physical forms. The IPO allotment status will be accessible via the MUFG Intime India Pvt Ltd portal, and the super speciality limited IPO is set to list on both BSE and NSE, with the expected listing date of December 30, 2025.
In summary, Gujarat Kidney and Super Speciality Limited is strategically positioned to benefit from the ongoing transformation in India’s healthcare sector. Its commitment to expanding tertiary care, investment in advanced medical technologies, and strong financial performance make the company—and its IPO—a compelling opportunity for investors seeking exposure to the dynamic multispeciality hospitals segment.
Gujarat Kidney IPO Allotment Status
The Gujarat Kidney IPO allotment status will be available after the basis of allotment is finalised. Investors can check the IPO allotment status page through MUFG Intime India Pvt Ltd using their application number or PAN.
How to Apply for Gujarat Kidney Super Speciality IPO
Retail investors can apply for the Gujarat Kidney Super Speciality IPO through:
Online IPO application via demat account
Stock broker platforms supported on BSE and NSE
UPI-based ASBA payment methods linked to bank account
Investors must review all IPO details, securities market disclosures, and risk factors carefully before applying.
Key Risks and Expansion Plans
The company operates in a high-capex healthcare sector with exposure to regulatory risks, outstanding secured borrowings, and capital expenditure requirements. However, hospital expansion plans, approved capacity growth, and investments in robotics equipment and new hospital infrastructure support long-term growth.
Conclusion: Should You Track Gujarat Kidney Super Speciality IPO?
The Gujarat Kidney Super Speciality IPO offers exposure to a fast-scaling regional healthcare provider with a focus on kidney and super speciality services. Strong revenue growth, improving profitability, and expanding hospital capacity position the company well within central Gujarat’s healthcare ecosystem. Investors tracking super speciality IPO opportunities should monitor IPO price band disclosures and valuation metrics closely.
Disclaimer: The information provided in our blogs is for informational purposes only and should not be construed as financial, investment, or trading advice. Trading and investing in the securities market carries risk. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Copyrighted and original content for your trading and investing needs.
© 2025 — Tradejini. All Rights Reserved.
